Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers—A mini‐review
暂无分享,去创建一个
[1] G. E. Carpagnano,et al. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases , 2016, Journal of breath research.
[2] Jianrong Chen,et al. Analysis of p16 gene mutations and their expression using exhaled breath condensate in non-small-cell lung cancer. , 2015, Oncology letters.
[3] J. C. Jongste,et al. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children – clinical tools or scientific toys? , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[4] S. Knuutila,et al. Driver Gene Mutations of Non-Small-Cell Lung Cancer are Rare in Primary Carcinoids of the Lung: NGS Study by Ion Torrent , 2015, Lung.
[5] I. Williamson,et al. The complexity and difficulty of diagnosing lung cancer: findings from a national primary-care study in Wales , 2014, Primary Health Care Research & Development.
[6] A. Shaw,et al. ALK inhibitors in non-small cell lung cancer: crizotinib and beyond. , 2014, Clinical advances in hematology & oncology : H&O.
[7] Y. Ishikawa,et al. Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: Different carcinogens may cause different genomic changes , 2014, Oncology reports.
[8] Cristina E. Davis,et al. Analysis of Volatile Compounds in Exhaled Breath Condensate in Patients with Severe Pulmonary Arterial Hypertension , 2014, PloS one.
[9] O. Araneda,et al. Increase of pro-oxidants with no evidence of lipid peroxidation in exhaled breath condensate after a 10-km race in non-athletes , 2014, Journal of Physiology and Biochemistry.
[10] K. Olsen,et al. Occupational Asbestos Exposure and Lung Cancer—A Systematic Review of the Literature , 2014, Archives of environmental & occupational health.
[11] Hans Kromhout,et al. Occupational Asbestos Exposure and Risk of Pleural Mesothelioma, Lung Cancer, and Laryngeal Cancer in the Prospective Netherlands Cohort Study , 2014, Journal of occupational and environmental medicine.
[12] A. Casalini,et al. Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[13] A. August,et al. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. , 2013, The Journal of allergy and clinical immunology.
[14] P. Thomas,et al. Exhaled breath condensate: a comprehensive update , 2013, Clinical chemistry and laboratory medicine.
[15] R. Lodha,et al. Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases. , 2013, The Journal of allergy and clinical immunology.
[16] P. Thomas,et al. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. , 2013, Respiratory medicine.
[17] D. Aberle,et al. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Lin,et al. Reply to comment on 'The effect of temperature on exhaled breath condensate collection' , 2012, Journal of breath research.
[19] J. Szemraj,et al. Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene. , 2012, Respiratory medicine.
[20] Alison J. Montpetit,et al. Exhaled breath condensate: an overview. , 2007, Immunology and allergy clinics of North America.
[21] G. E. Carpagnano,et al. Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion? , 2012, Rejuvenation research.
[22] H. Koskela,et al. Asthmatic cough and airway oxidative stress , 2012, Respiratory Physiology & Neurobiology.
[23] E. Kovacs,et al. Exhaled breath condensate collection in the mechanically ventilated patient. , 2012, Respiratory medicine.
[24] T. Greulich,et al. Comparison of Two Devices and Two Breathing Patterns for Exhaled Breath Condensate Sampling , 2011, PloS one.
[25] K. Kiura,et al. Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung. , 2011, Lung cancer.
[26] G. E. Carpagnano,et al. HPV in exhaled breath condensate of lung cancer patients , 2011, British Journal of Cancer.
[27] P. Thomas,et al. Standardization of exhaled breath condensate: effects of different de-aeration protocols on pH and H2O2 concentrations , 2011, Journal of breath research.
[28] D. Wakefield,et al. The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques , 2011, Inflammopharmacology.
[29] T. Brüning,et al. Increased metal concentrations in exhaled breath condensate of industrial welders. , 2011, Journal of environmental monitoring : JEM.
[30] D. Yates,et al. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications , 2010, Journal of breath research.
[31] G. E. Carpagnano,et al. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients. , 2010, Lung cancer.
[32] Q. Jöbsis,et al. Feasibility of a new method to collect exhaled breath condensate in pre‐school children , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[33] A. A. Reilly,et al. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients , 2009, Respiratory research.
[34] A. Spanevello,et al. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. , 2009, Lung cancer.
[35] D. Rea,et al. Role of tyrosine kinase inhibitors in lung cancer. , 2009, Anti-cancer agents in medicinal chemistry.
[36] T. Bengtsson,et al. Exhaled breath condensate—site and mechanisms of formation , 2009, Journal of breath research.
[37] L. Nordvall,et al. Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. , 2009, Respiratory medicine.
[38] S. Lippman,et al. Lung cancer. , 2008, The New England journal of medicine.
[39] Z. Borrill,et al. Exhaled breath condensate biomarkers in COPD , 2008, European Respiratory Journal.
[40] G. Mills,et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.
[41] Ildikó Horváth,et al. Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. , 2008, Respiratory medicine.
[42] Q. Jöbsis,et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers , 2008, European Respiratory Journal.
[43] R. Matran,et al. Cytokine concentrations in exhaled breath condensates in systemic sclerosis , 2008, Inflammation Research.
[44] A. Paradiso,et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. , 2008, American journal of respiratory and critical care medicine.
[45] U. Range,et al. Exhaled breath condensate pH in infants and children with acute and recurrent wheezy bronchitis , 2007, Pediatric pulmonology.
[46] A Mutti,et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults , 2007, European Respiratory Journal.
[47] D. Yates,et al. Collection devices influence the constituents of exhaled breath condensate , 2007, European Respiratory Journal.
[48] J. Jen,et al. Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. , 2007, Mitochondrion.
[49] Sten Orrenius,et al. Mitochondria, oxidative stress and cell death , 2007, Apoptosis.
[50] D. Yates,et al. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. , 2007, American journal of respiratory and critical care medicine.
[51] R. Guleria,et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. , 2006, Clinical chemistry.
[52] O. Kalayci,et al. Comparison of two methods for exhaled breath condensate collection , 2006, Allergy.
[53] P. Apostoli,et al. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. , 2006, Chest.
[54] F. Emmrich,et al. Multiplex analysis of cytokines in exhaled breath condensate , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[55] S. Stick,et al. Measuring Exhaled Breath Condensates in Infants , 2006, Pediatric pulmonology.
[56] P. Montuschi,et al. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD , 2005, Thorax.
[57] A. Paradiso,et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. , 2005, American journal of respiratory and critical care medicine.
[58] M. Corradi,et al. Influence of condensation temperature on selected exhaled breath parameters , 2005, BMC pulmonary medicine.
[59] P. J. Barnes,et al. Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.
[60] A. Maitra,et al. Mitochondrial DNA as a cancer biomarker. , 2005, The Journal of molecular diagnostics : JMD.
[61] M. Corradi,et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. , 2005, The Journal of allergy and clinical immunology.
[62] S. Ohta,et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. , 2005, Cancer research.
[63] H. Kuhn,et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. , 2004, Lung cancer.
[64] Q. Jöbsis,et al. Exhaled breath condensate in children: Pearls and pitfalls , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[65] A Smith,et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity , 2003, European Respiratory Journal.
[66] S. Toyooka,et al. Alterations in the mitochondrial displacement loop in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] P. Montuschi,et al. CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease , 2003, Thorax.
[68] Mitsuhiro Osame,et al. Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer , 2003, Human mutation.
[69] I. Horváth,et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. , 2003, American journal of respiratory and critical care medicine.
[70] I. Horváth,et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma , 2002, European Respiratory Journal.
[71] M. Gare,et al. Dilution of respiratory solutes in exhaled condensates. , 2002, American journal of respiratory and critical care medicine.
[72] J. T. Wachsman,et al. Mitochondrial DNA in human malignancy. , 2001, Mutation research.
[73] H. Magnussen,et al. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. , 2000, The European respiratory journal.
[74] J. Jen,et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.
[75] J. Herman,et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.
[76] B. Christman,et al. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. , 1998, Chest.
[77] R. Schlapbach,et al. Oxidants in mitochondria: from physiology to diseases. , 1995, Biochimica et biophysica acta.
[78] Ping Xiao,et al. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. , 2014, Lung cancer.
[79] M. Fleischhacker,et al. Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.
[80] G. Kroemer,et al. The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.
[82] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[83] M. Stroun,et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.
[84] J. Higginson,et al. International Agency for Research on Cancer. , 1968, WHO chronicle.